creatine has been researched along with Ventilator-Associated Pneumonia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Polymyxin B treatment in the currently recommended dosage may be inferior to other drugs in the treatment of VAP and VAT caused by organisms tested as susceptible in vitro to this agent." | 1.39 | Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii. ( Konzen, D; Ribeiro, VB; Rigatto, MH; Zavascki, AP, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rigatto, MH | 1 |
| Ribeiro, VB | 1 |
| Konzen, D | 1 |
| Zavascki, AP | 1 |
1 other study available for creatine and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; APACHE; Bronc | 2013 |